Skip to content

Effectiveness of Ayurvedic formulation in the management of Dadru kustha with special reference to Tinea.

A Comparative Clinical & In-Vitro Study To Evaluate The Antifungal Activity Of Dadruhara Yoga With and Without Go-mutra In The Management Of Dadru Kustha With Special Reference To Tinea

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/038863
Enrollment
120
Registered
2021-12-23
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Subhrajyoti Chakraborty
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient will assess and diagnose thoroughly on the basis of Ayurvedic classical signs and symptoms further confirmed by the signs and symptoms of Dermatophytosis with special reference to Tinea Corporis in modern texts. Only KOH(potassium hydroxide) positive confirming caese will be consider. Those who will be ready to give written consent either in Hindi or English

Exclusion criteria

Exclusion criteria: Patients with other systemic disorders like Diabetes Mellitus,HIV etc Patients on prolonged immunosuppressant and antibiotic therapy. Chronic and severe cases associated with complications or secondary infection Treated case and those who received topical antifungal within 1week before baseline visit. pregnancy and lactation.

Design outcomes

Primary

MeasureTime frame
Relief in the signs and symptoms of Dadru kustha and to evaluate the efficacy of Dadruhara yoga as external application in patients of DadruTimepoint: 30 days Assessment will done on 1st, 15th and 30th day of visit and follow upto 45th day

Secondary

MeasureTime frame
To assess the efficacy of Ayurvedic intervention in comparison to Modern intervention clinically as well as in vitro. Asses the improvement in the quality of lifeTimepoint: 30 days

Countries

India

Contacts

Public ContactDr Shalini

Institute of Medical Sciences, Banaras Hindu University

dr.shalini@bhu.ac.in9785520474

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026